Alzheimer′s disease - Not an exaggeration of healthy aging

Indian Journal of Psychological Medicine

Volumn 33, Issue 2, 2011, Pages 106-114

  Ghosh, Krishnendu ^a   Agarwal, Pratibha ^a   Haggerty, Greg ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer s disease; cerebrospinal fluid; functional magnetic resonance imaging; positron emission tomography scan; prefontral corex; subjective cognitive complains; whole brain volume

Indexed keywords

EID: 84856432909     PISSN: 02537176     EISSN: 09751564     Source Type: Journal    
DOI: 10.4103/0253-7176.92047     Document Type: Review

References (83)

1. Galluzzi S, Frisoni GB. Imaging, subjective complaints and MCI: 30 years before. J Nutr Health Aging 2008;12:80s-3s. (Pubitemid 351156020)
2. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, et al . Regional brain changes in aging healthy adults: General trends, individual differences and modifiers. Cereb Cortex 2005;15:1676-89. (Pubitemid 41447032)
3. Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS, et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998;155:344-9. (Pubitemid 28114890)
4. Salthouse TA, Atkinson TM, Berish DE. Executive functioningas a potential mediator of age-related cognitive decline in normal adults. J Exp Psychol Gen 2003;132:566.
5. Nielson KA, Langenecker SA, Ross TJ, Garavan H, Rao SM, Stein EA. Comparability of functional MRI response in young and old during inhibition. Neuroreport 2004;15:129-33. (Pubitemid 41614985)
6. Johnson MK, Mitchell KJ, Raye CL, Greene EJ. An age-related deficit in prefrontal cortical function associated with refreshing information. Psychol Sci 2004;15:127-32. (Pubitemid 38361305)
7. Grady CL, Springer MV, Hongwanishkul D, McIntosh AR, Winocur G. Age-related changes in brain activity across the adult lifespan. J Cogn Neurosci 2006;18:227-41.
8. Madden DJ, Whiting WL, Provenzale JM, Huettel SA. Age-related changes in neural activity during visual target detection measured by fMRI. Cereb Cortex 2004;14:143-55. (Pubitemid 38141529)
9. Rypma B, Berger JS, Genova HM, Rebbechi D, D'Esposito M. Dissociating age-related changes in cognitive strategy and neural efficiency using event-related fMRI. Cortex 2005;41:582-94. (Pubitemid 40932321)
10. Reuter-Lorenz PA, Jonides J, Smith EE, Hartley A, Miller A, Marshuetz C, et al . Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci 2000;12:174-87. (Pubitemid 30142792)
11. Reuter-Lorenz PA, Lustig C. Brain aging: Reorganizing discoveries about the aging mind. Curr Opin Neurobiol 2005;15:245.
12. Esposito G, Kirkby BS, Van Horn JD, Ellmore TM, Berman KF. Context-dependent, neural system-specific neurophysiological concomitants of ageing: Mapping PET correlates during cognitive activation. Brain 1999;122:963-79. (Pubitemid 29219268)
13. Shimamura AP. Neuropsychological perspectives on memory and cognitive decline in normal human aging. Seminar in Neurosci 1994;6:387-94.
14. Anstey KJ, Low LF. Normal cognitive Changes With aging. Aust Fam Physician 2004;33:783-7.
15. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging 2009;30:507-14.
16. Christensen H. What cognitive changes can be expected with normal ageing? Aust NZ J Psychiat 2001;35:768-75. (Pubitemid 34048448)
17. Klimesch W Doppelmayr M, Pachinger T, Ripper B, Barain Oscillation and Human Memory: EEG correlates in the upper Alpha and theta Band. NeurosienceLett 1997;238:9-12. (Pubitemid 28015771)
18. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Res Brain Res Rev 1999;29:169-95. (Pubitemid 29191338)
19. Babiloni C, Binetti G, Cassarino A, Dal Forno G, Del Percio C, Ferreri F et al. Sources of cortical rhythms in adults during physiological aging: A multicentric EEG study. Hum Brain Mapp 2006;27:162-72. (Pubitemid 43238488)
20. Huang C, Wahlund L, Dierks T, Julin P, Winblad B, Jelic V Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: A cross-sectional and longitudinal study. Clin Neurophysiol 2000;111:1961-7.
21. Lauer CJ, Riemann D, Wiegand M, Berger M. From early to late adulthood changes in EEG sleep of depressed patients and healthy volunteers. Biological Psychiatry 1991;29:979-93.
22. Petit D, Montplaisir J, Riekkinen P Sr, Soininen H, riekkinen P Jr. Electrophysiological test. In Gauthier S. Clinical diagnosis of management of Alzheimer's disease, Taylor and Francis, 2000, PP 137-138.
23. Fernández A, Maestú F Amo C, Gil P, Fehr T, Wienbruch C, et al . Focal temporoparietal slow activity in Alzheimer's disease revealed by magnetoencephalography. Biol Psychiatry 2002;52:764-70.
24. Von Dras DD, Blumenthal HT. Dementia of the aged: Disease or atypical-accelerated aging? Biopathological and psychological perspectives. J Am Geriatr Soc 1992;40:285-94.
25. Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol 1997;56:1269-75. (Pubitemid 28006572)
26. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol 1987;21:530-9. (Pubitemid 17081187)
27. Hatanpaa K, Isaacs KR, Shirao T, Brady DR, Rapoport SI. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J Neuropathol Exp Neurol 1999;58:637-43. (Pubitemid 29264943)
28. Double KL, Halliday GM, Kril JJ, Harasty JA, Cullen K, Brooks WS, et al . Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol Aging 1996;17:513-21. (Pubitemid 26274249)
29. Raz N, Gunning FM, Head D, Dupuis JH, McQuain J, Briggs SD, et al. Selective aging of the human cerebral cortex observed in vivo: Differential vulnerability of the prefrontal gray matter. Cereb Cortex 1997;7:268-82. (Pubitemid 27184486)
30. Lim KO, Zipursky RB, Watts MC, Pfefferbaum A. Decreased gray matter in normal aging: An in vivo magnetic resonance study. J Gerontol 1992;47:b26-30.
31. Guttmann CR, Killiany RJ, Moss MB, Sandor T, Albert MS, Jolesz FA. White matter changes with normal aging. Neurobiology 1998;50:972-8. (Pubitemid 28212824)
32. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL. Brain volume decline in aging: Evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol 2008;65:113-120.
33. Ohnishi T, Matsuda H, Tabira T, Asada T, Uno M. Changes in brain morphology in Alzheimer disease and normal aging: Is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol 2001;22:1680-5. (Pubitemid 32999576)
34. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: A shrinking brain. J Neurosci 2003;23:3295-301. (Pubitemid 36531970)
35. Raz N, Gunning-Dixon F Head D, Rodrigue KM, Williamson A, Acker JD. Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: Replicability of regional differences in volume. Neurobiol Aging 2004;25:377-96. (Pubitemid 38220973)
36. Raz N, Gunning-Dixon FM, Head D, Dupuis JH, Acker JD. Neuro anatomical correlates of cognitive aging: Evidence from structural magnetic resonance imaging. Neuropsychology 1998;12:95-114. (Pubitemid 28070401)
37. Salat DH, Kaye JA, Janowsky JS. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol 2001;58:140.
38. Gunning-Dixon FM, Head D, McQuain J, Acker JD, Raz N. Differential aging of the human striatum: A prospective MR imaging study. AJNR Am J Neuroradiol 1998;19:1501-7. (Pubitemid 30431045)
39. Raz N,Rodrigue KM, Head D, Kennedy KM, Acker JD. Differential aging of the medial temporal lobe: A study of a five-year change. Neurology 2004;62:433-8. (Pubitemid 38200856)
40. Thompson PM,Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, et al. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 2004;22:1754-66. (Pubitemid 38962663)
41. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P Hänninen T, Laakso MP, et al . Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004;25:303-10. (Pubitemid 38220965)
42. Ge Y, Grossman RI, Babb JS, Rabin ML, Mannon LJ, Kolson DL. Age-related total gray matter and white matter changes in normal adult brain. Part I: Volumetric MR Imaging Analysis. AJNR Am J Neuroradiol 2002;23:1327-33. (Pubitemid 35033881)
43. Alavi A, Hirsch LJ. Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: Evolution over the past 2 decades. Semin Nucl Med 1991;21:58-81.
44. Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE. Regional cerebral function determined by FDG -PET in healthy volunteers: Normal patterns and changes with age. J Nucl Med 1995;36:1141-9.
45. Kumakura Y, Vernaleken I, Gründer G, Bartenstein P, Gjedde A, Cumming P. PET studies of net blood-brain clearance of FDOPA to human brain: Age-dependent decline of [18F]fluoro dopamine storage capacity. J Cereb Blood Flow Metab 2005;25:807-19. (Pubitemid 40905608)
46. Yoshii F, Barbar WW, Aracy JY, Loewenstein D, Apicella A, Smith D, et al. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy and cerebrovascular risk factors. J Cereb Blood Flow Metab 1988;8:654-61.
47. Kantarci K, Senjem ML, Lowe VJ, Wiste HJ, Weigand SD, Kemp BJ, et. al. Effects of age on the glucose metabolic changes in mild cognitive impairment. AJNR Am J Neuroradiol 2010;31(7):1247-53.
48. Erixon-Lindroth N, Farde L, Wahlin TB, Sovago J, Halldin C, Bäckman L. The role of the striatal dopamine transporter in cognitive aging. Psychiatry Res 2005;138:1-12. (Pubitemid 40228957)
49. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, MacGregor RR, et al . Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res 1996;67:11-6.
50. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc Natl Acad Sci USA 1985;82:4245-9. (Pubitemid 15053619)
51. Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, et al . APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 2010;67:122-31.
52. Haldenwanger A, Eling P, Kastrup A, Hildebrandt H. Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease. J Alzheimers Dis 2010;22:971-80.
53. Glenner GG, Wong CW. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-90. (Pubitemid 14104991)
54. Barak H. Architectonics of the human telencephalic cortex. Berlin: Springer; 1980. p. 1-147.
55. Braak H, Braak E. Neuropathological staging of Alzheimer's related changes. Acta Neuropathol 1991;82:239-59.
56. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories, neurobiology of aging. 1997;18:351-7. (Pubitemid 27435070)
57. Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science, Vol. 278, 17 October 1997. Available from: http://www.sciencemag.org. [Last cited on 2011 Jun 08]
58. Carlesimo GA, Cherubini A, Caltagirone C, Spalletta G. Hippocampal mean diffusivity and memory in healthy elderly individuals: A cross-sectional study. Neurology 2010;74:194-200.
59. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: A magnetic resonance imaging study. Arch Neurol 2003;60:393-8. (Pubitemid 36314365)
60. Bartzokis G. Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004;25:5-18; author reply 49-62. (Pubitemid 37522186)
61. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J,Cummings JL. Heterogeneous age-related breakdown of white matter structural integrity: Implications for cortical disconnection in aging and Alzheimer's disease. Neurobiol Aging 2004;25:843-51. (Pubitemid 38813164)
62. Di Paola M, Luders E, Di Iulio F, Varsi AE, Sancesario G, Passafiume D, et al . Callosal atrophy in mild cognitive impairment and Alzheimer's disease: Different effects in differentstages. Neuroimage 2010;49:141-9.
63. Forester BP, Berlow YA, Harper DG, Jensen JE, Lange N, Froimowitz MP, et al . Age-related changes in brain energetics and phospholipid metabolism. NMR Biomed 2010;23:242-50.
64. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, et al . Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 1991;88:10540-3. (Pubitemid 21915871)
65. Volkow ND, Wang GJ, Fowler JS, Ding YS, Gur RC, Gatley J, et al. Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging. Ann Neurol 1998;44:143-7. (Pubitemid 28323668)
66. Severson JA, Marcusson J, Winblad B, Finch CE. Age-correlated loss of dopamin ergic binding sites in human basal ganglia. J Neurochem 1982;39:1623-31. (Pubitemid 13184139)
67. McGeer PL, McGeer EG, Suzuki JS. Aging and extrapyramidal Function. Arch Neurol 1977;34:33-5. (Pubitemid 8020106)
68. Morgan DG. The dopamine and serotonin systems during aging in human and rodent brain. A brief review. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:153-7. (Pubitemid 17120285)
69. Volkow ND, Logan J, Fowler JS, Wang GJ, Gur RC, Wong C, et al . Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry 2000;157:75-80. (Pubitemid 30027424)
70. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution. Brain 1999;122:1449-68. (Pubitemid 29374123)
71. Reeves S, Brown R, Howard R, Grasby P.Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease. AJNR Am J Neurol 2009;72:528-34.
72. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982;215: 1237-9. (Pubitemid 12106486)
73. Sims NR, Bowen DM, Allen SJ, Smith CC, Neary D, Thomas DJ, et al . Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 1983;40:503-9. (Pubitemid 13195690)
74. Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, et al . Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med 1985;313:7-11. (Pubitemid 15068737)
75. Francis PT, Sims NR, Procter AW, Bowen DM. Cortical pyramidal neurone loss may cause glutamatergichypo-activity and cognitive impairment in Alzheimer's disease: Investigative and therapeutic perspectives. J Neurochem 1993;60:1589-604. (Pubitemid 23127561)
76. Gsell W, Strein I, Riederer P. The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared. J Neural Transm Suppl 1996;47:73-101. (Pubitemid 26275591)
77. Tohgi H, Utsugisawa K, Yoshimura M, Nagane Y Mihara M. Age-related changes in nicotinic acetylcholine receptor subunits α4 and ß2 messenger RNA expression in postmortem human frontal cortex and hippocampus. Neurosci Lett 1998;245:139-42. (Pubitemid 28287342)
78. Utsugisawa K, Nagane Y Tohgi H, Yoshimura M, Ohba H, Genda Y Changes with aging and ischemia in nicotinic acetylcholine receptor subunit α7 mRNA expression in postmortem human frontal cortex and putamen. Neurosci Lett 1999;270:145-8. (Pubitemid 29343575)
79. Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991;253:1380-6. (Pubitemid 21917285)
80. Villares JC, Stavale JN. Age-Related Changes in the N-Methyl-aspartate receptor binding sites within the human basal ganglia. Exp Neurol 2001;171:391-404. (Pubitemid 32955300)
81. Danysz W, Parsons CG, Möbius HJ, Stöffler A, Quack G. Neuroprotective and symptomalogical action of memantine relevant for Alzheimer's disease: A unified glutamatergic hypothesis on the mechanism of action. Neurotox Res 2000;2:85-97.
82. Procter AW, Francis PT, Holmes C, Webster MT, Qume M, Stratmann GC, et al . Beta-amyloid precursor protein isoforms show correlations with neurones but not with glia of demented subjects. Acta Neuropathol 1994;88:545-52. (Pubitemid 24364702)
83. Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, et al . The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: The role of Abeta1-42. J Neurochem 2001;78:413-6. (Pubitemid 32664423)